ArticleBMC endocrine disorders2022

Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma.

Fangshi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.